EASD 2026
28 September - 2 October 2026
Semaglutide in obesity care: comprehensive evidence and emerging science
Tuesday, 29 September 2026
18:00 - 18:10
(CEST)
Opening the conversation on modern obesity treatments
Jaime Almandoz
18:10 - 18:35
(CEST)
Oral and injectable semaglutide: weight loss across formulations
Sean Wharton
18:35 - 19:00
(CEST)
From weight loss to health gain: the broader benefits of semaglutide
Barbara McGowan
19:00 - 19:10
(CEST)
Where evidence meets clinical practice
Jaime Almandoz, Sean Wharton, Barbara McGowan, Liana Billings
19:10 - 19:25
(CEST)
The next frontier: exploring amylin and complementary pathways
Liana Billings
19:25 - 19:30
(CEST)
The conversation continues
Jaime Almandoz
Keywords